ANANDA Scientific Announces FDA approval of the IND for the Clinical Trial on the Treatment of Opioid Use Disorder (OUD)

ANANDA Scientific Inc., (a biotech pharma company) today announced approval by the U.S. Food and Drug Administration (FDA) of the Investigational New

The Opioid Crisis and Recent Federal Policy Responses

TESCREAL hallucinations: Psychedelic and AI hype as inequality engines in: Journal of Psychedelic StudiesOnline First

PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment, Addiction Science & Clinical Practice

The Opioid Crisis and Recent Federal Policy Responses

g556911.jpg

Substance Abuse Treatment Market Size & Share Analysis - Industry Research Report - Growth Trends

Public Comment Index for the National Alzheimer's Project Act

Ananda Scientific (@AnandaScience) / X

Ananda Scientific (@AnandaScience) / X

MUSC Catalyst News, MUSC

Substance Abuse Treatment Market Size & Share Analysis - Industry Research Report - Growth Trends

ANANDA Scientific Announces FDA approval of the IND for the Clinical Trial on the Treatment of Opioid Use Disorder (OUD)